Search hospitals > Michigan > Reed City

Spectrum Health Reed City Hospital

Claim this profile
Reed City, Michigan 49677
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Non-Small Cell Lung Cancer
250 reported clinical trials
1 medical researcher
Photo of Spectrum Health Reed City Hospital in Reed CityPhoto of Spectrum Health Reed City Hospital in Reed CityPhoto of Spectrum Health Reed City Hospital in Reed City

Summary

Spectrum Health Reed City Hospital is a medical facility located in Reed City, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Spectrum Health Reed City Hospital is involved with conducting 250 clinical trials across 446 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.

Area of expertise

1Cancer
Global Leader
Spectrum Health Reed City Hospital has run 92 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Spectrum Health Reed City Hospital has run 39 trials for Breast Cancer. Some of their research focus areas include:
HER2 negative
Stage IV
ER positive

Top PIs

Clinical Trials running at Spectrum Health Reed City Hospital

Breast Cancer
Non-Small Cell Lung Cancer
Cancer
Lung Cancer
Melanoma
Cutaneous Melanoma
Pancreatic Cancer
Multiple Myeloma
Gastric Cancer
Oropharyngeal Carcinoma
Image of trial facility.

Chemotherapy + Hormone Therapy

for Breast Cancer

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Carvedilol

for Preventing Heart Problems in HER2 Positive Breast Cancer

This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at Spectrum Health Reed City Hospital?
Spectrum Health Reed City Hospital is a medical facility located in Reed City, Michigan. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Adenocarcinoma, Non-Small Cell Lung Cancer and other specialties. Spectrum Health Reed City Hospital is involved with conducting 250 clinical trials across 446 conditions. There are 1 research doctors associated with this hospital, such as Kathleen J. Yost.